Biosensors Market Size To Reach $63.96 Billion By 2033

Biosensors Market Growth & Trends

The global biosensors market size is estimated to reach USD 63.96 billion by 2033, expanding at a CAGR of 9.12% from 2026 to 2033, according to a new report by Grand View Research, Inc. The key factors driving the industry growth include various applications in the healthcare/medical sector, increasing demand in the bioprocessing industry, and rapid technological advancements in drug screening due to the COVID-19 pandemic. Moreover, the pandemic led to the rapid expansion of the biosensor industry due to an increase in the number of hospitals worldwide.

Over the forecast period, technological advancements are expected to be significant growth drivers for the industry. For example, in January 2022, a U.S. medical device manufacturer, Abbott, launched a universal consumer wearable device with biosensors. The company announced the development of a new line of consumer biometric wearable devices called Lingo, designed for more general fitness and wellness purposes. In addition, increasing demand for biosensors and bioreactors for new drug development is likely to lead to industry expansion in the near future due to improved biosensor technology.

 Request a free sample copy or view report summary: Biosensors Market Report

Biosensors Market Report Highlights

• The electrochemical biosensors technology segment accounted for the largest revenue share in 2025.

• The segment is anticipated to witness significant growth over the forecast period owing to the widespread applications for analysis & quantification in biochemical and biological processes.

• Based on the application, the medical segment dominated the industry in 2025. This device is considered an essential tool in the monitoring and detection of a wide range of medical conditions, such as cancer and diabetes.

• Middle East & Africa is expected to witness the fastest growth rate over the forecast period.

• This is owing to a rise in research & development activities and constantly improving healthcare facilities in the region.

Biosensors Market Segmentation

Grand View Research has segmented the global biosensors market based on technology, application, end use, and region:

Biosensors Technology Outlook (Revenue, USD Million, 2021 - 2033)

• Thermal

• Electrochemical

• Piezoelectric

• Optical

Biosensors Application Outlook (Revenue, USD Million, 2021 - 2033)

• Medical

  • Cholesterol

  • Blood Glucose

  • Blood gas analyzer

  • Pregnancy testing

  • Drug discovery

  • Infectious disease

• Food Toxicity

• Bioreactor

• Agriculture

• Environment

• Others

Biosensors End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Home Healthcare Diagnostics

• PoC Testing

• Food Industry

• Research Laboratories

• Security and Bio-defense

Biosensors Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Biosensors Market

• Abbott Laboratories

• Medtronic

• Biosensors International Group

• Pinnacle Technology, Inc.

• Dupont.

• Sensirion AG

• Thermo Fisher Scientific, Inc.

• F. Hoffmann-La Roche

• Siemens Healthineers

• Zimmer & Peacock AS

• Metrohm AG

• DexCom, Inc.

• Universal Biosensors, Inc.

• Johnson & Johnson Services, Inc.

• Nix Biosensors

• Cyrcadia Health

• Lifescan